Mashup Score: 2
American Society of Hematology PublicationsAbstract. Background: So far, planning of clinical trials in multiple myeloma (MM) has been based on traditional outcome measures such as progression free (PFS)
Mashup Score: 2
American Society of Hematology PublicationsAbstract. Background: So far, planning of clinical trials in multiple myeloma (MM) has been based on traditional outcome measures such as progression free (PFS)
We like to assume what patients want- but a substantial minority prefer PFS over QOL in the maintenance setting. Very thought provoking.